F8 and hemophilia A: <b>Objective:</b> To evaluate the long-term efficacy and safety of recombinant coagulation factor VIII (Octocog alfa) in Chinese patients with hemophilia A (HA) enrolled in the International Antihemophilic Factor Hemophilia A Outcome Database (AHEAD) study (NCT02078427) .